Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Cybrdi, Inc.
| Metric | Cybrdi, Inc. Healthcare |
|---|---|
| Quality Score | 18 / 100 |
| Revenue (latest) | $574,261 |
| Net income (latest) | −$548,366 |
| Operating margin | −94.4% |
| Net margin | −95.5% |
| Return on equity | −18.6% |
| Return on assets | −5.3% |
| Return on capital (ROCE) | −12.4% |
| Debt / equity | 2.15× |
| Revenue growth (YoY) | −26.7% |
| Altman Z″ (distress) | -3.52 |
| Accruals / assets | 5.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.